1. Catalogs
  2. R&D Systems
  3. Recombinant Human Ubiquitin‑activating Enzyme/UBE1

Recombinant Human Ubiquitin‑activating Enzyme/UBE1

Recombinant Human Ubiquitin‑activating Enzyme/UBE1

Product catalog summary
Specifications
Recombinant Human Ubiquitin Activating Enzyme (UBE1) is a crucial enzyme in the ubiquitin-proteasome pathway, initiating the ubiquitin conjugation process. It is recommended to use a concentration of 50-200 nM for optimal activity. The enzyme is over 95% pure as determined by SDS-PAGE and is supplied in a solution containing HEPES, NaCl, and TCEP.
Preparation and Storage
The enzyme is shipped with dry ice and should be stored at -70°C. It remains stable for 6 months from receipt and 3 months after opening under sterile conditions. Avoid repeated freeze-thaw cycles to maintain stability.
Background
UBE1, also known as UBA1, is a 1058 amino acid enzyme with a molecular weight of 118 kDa. It is highly conserved across species and plays a vital role in cell cycle progression and DNA damage response. UBE1 mutations are linked to X-linked lethal infantile spinal muscular atrophy. The enzyme activates ubiquitin, forming a thioester bond with a cysteine residue, which is then transferred to target proteins through a cascade involving E2 and E3 enzymes.
References
The document cites several studies and articles that provide detailed insights into the function and importance of UBE1 in cellular processes.
See more

Catalog excerpts

Recombinant Human Ubiquitin‑activating Enzyme/UBE1-1

Recombinant Human Ubiquitin-activating Enzyme/UBEI Catalog Number: E-305DESCRIPTION Source Spodoptera frugiperda, Sf 21 (baculovirus)-derived human Ubiquitin-activating Enzyme/UBEI protein Accession # P22314.3 Predicted Molecular 118 kDa Mass Activity Recombinant Human Ubiquitin Activating Enzyme (UBE1) is a member of the Ubiquitin-activating (E1) enzyme family that is required for the first step of the enzymatic cascade that subsequently utilizes a Ubiquitin-conjugating (E2) enzyme and a Ubiquitin ligase (E3) to conjugate Ubiquitin to substrate proteins. Reaction conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human Ubiquitin Activating Enzyme (UBE1) concentration of 50-200 nM. Purity >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain. Formulation Supplied as a solution in HEPES, NaCl and TCEP. See Certificate of Analysis for details. Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. • 6 months from date of receipt, -70 °C as supplied. • 3 months, -70 °C under sterile conditions after opening. Ubiquitin-activating Enzyme (UBE1), also known as Ubiquitin-like Modifier Activating Enzyme 1 (UBA1), is a 1058 amino acid (aa) canonical member of the Ubiquitin-activating (E1) enzyme family of proteins with a predicted molecular weight of 118 kDa. It is ubiquitously expressed and highly conserved; mouse and rat UBE1 share 95% and 96% aa sequence identity with the human UBE1 protein, respectively. UBE1 is found in the cytoplasm and nucleus, and contains a conserved active-site cysteine residue and ATP-binding site common to E1 enzymes (1-3). UBE1 is responsible for the first step in Ubiquitin-protein isopeptide bond formation (4,5). Ubiquitin is activated by UBE1 and thereafter linked to the side chain of a cysteine residue in UBE1, Cys632 in humans, yielding a Ubiquitin-UBE1 conjugate via a thioester bond (5-8). The activated Ubiquitin is then transferred to a lysine residue on the target protein via the Ubiquitin-conjugating - Ubiquitin ligase enzyme cascade. UBE1 is required for cell cycle progression and has been linked to cellular responses to DNA damage such as nucleotide excision repair (3,9,10). Mutations in UBE1 are associated with X-linked lethal infantile spinal muscular atrophy (11). UBE1 is a critical component for the initiation of in vitro ubiquitin conjugation reactions. References: 1. Handley, P.M. et al. (1991) Proc. Natl. Acad. Sci. USA 88:258. 3. Stephen, A.G. et al. (1996) J. Biol. Chem. 271:15608. 4. Hershko, A. et al. (1983) J. Biol. Chem. 258:8206. 5. Schulman, B.A. & J.W. Harper (2009) Nat. Rev. Mol. Cell Biol. 10:319. 6. Haas, A.L. et al. (1982) J. Biol. Chem. 257:2543. 7. Haas, A.L. & I.A. Rose (1982) J. Biol. Chem. 257:10329. 8. Pickart, C.M. et al. (1994) J. Biol. Chem. 269:7115. 9. Nouspikel, T. & P.C. Hanawalt (2006) Proc. Natl. Acad. Sci. USA 103:16188. 10. Moundry, P. et al. (2012) Cell Cycle 11:1573. Global bio-techne.com [email protected] [email protected] TEL +1612 379 2956 USA TEL 800 343 7475 Canada TEL 855 668 8722 China TEL +86 (21) 52380373 Europe | Middle East | Africa TEL +44 (0)1235 529449

 Open the catalog to page 1
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.